Acquisition of human concentrative nucleoside transporter 2 (hCNT2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells
Tt. Lang et al., Acquisition of human concentrative nucleoside transporter 2 (hCNT2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells, MOLEC PHARM, 60(5), 2001, pp. 1143-1152
CEM-ARAC leukemia cells with resistance to cytarabine were shown to lack eq
uilibrative transporter (hENT1) expression and activity. Stable transfer of
hCNT2 cDNA into CEM-ARAC enabled Na+-dependent transport of purine and pyr
imidine nucleoside analogs and provided a unique in vitro model for studyin
g hCNT2. Analysis of [H-3]uridine inhibitory activity by test substances in
hCNT2 transfectant ARAC/D2 revealed structural requirements for interactio
n with hCNT2: 1) ribosyl and 2'-deoxyribosyl nucleosides were better inhibi
tors than 3'-deoxyribosyl, 2',3'-dideoxyribosyl or arabinosyl nucleosides;
2) uridine analogs with halogens at position 5 were better inhibitors than
5-methyluridine or thymidine; 3) 2-chloroadenosine was a better inhibitor t
han 2-chloro-2'-deoxyadenosine (cladribine); and 4) cytosine-containing nuc
leosides, 7-deazaadenosine and nucleobases were not inhibitors. Quantificat
ion of inhibitory capacity yielded K-i values of 34-50 muM (5-halogenated u
ridine analogs, 2'-deoxyuridine), 82 muM (5-fluoro-2'-deoxyuridine), 197-24
6 muM (5-methyluridine < 5-bromo-2'-deoxyuridine < 5-iodo-2'-deoxyuridine),
and 411 muM (5-fluoro-5'-deoxyuridine, capecitabine metabolite). Compariso
ns of hCNT2-mediated transport rates indicated halogenated uridine analogs
were transported more rapidly than halogenated adenosine analogs, even thou
gh hCNT2 exhibited preference for physiologic purine nucleosides over uridi
ne. Kinetics of hCNT2-mediated transport of 5-fluorouridine and uridine wer
e similar (K-m values, 43-46 muM). The impact of hCNT2-mediated transport o
n chemosensitivity was assessed by comparing antiproliferative activity of
nucleoside analogs against hCNT2-containing cells with transport-defective,
drug-resistant cells. Chemosensitivity was restored partially for cladribi
ne, completely for 5-fluorouridine and 5-fluoro-2'-deoxyuridine, whereas th
ere was little effect on chemosensitivity for fludarabine, 7-deazaadenosine
, or cytarabine. These studies, which demonstrated hCNT2 uptake of halogena
ted uridine analogs, suggested that hCNT2 is an important determinant of cy
totoxicity of this class of compounds in vivo.